脾切除联合贲门周围血管离断术治疗肝硬化门脉高压症患者预防门静脉血栓形成研究

doi:10.3969/j.issn.1672-5069.2020.03.027

摘要/Abstract

摘要： 目的探讨脾切除联合贲门周围血管离断术治疗肝硬化门脉高压症患者门静脉血栓(PVT)的预测措施。方法 2017年1月～2019年3月我院肝胆外科诊治的肝硬化并发门脉高压症患者60例,均接受脾切除联合贲门周围血管离断术。术后将患者分成A组和B组。在B组,当出现抗凝指针时给予低分子肝素短期抗凝治疗。使用彩超检查门脉指标和诊断PVT形成。结果术后,在B组30例患者中有20例(66.7%)接受了短期抗凝治疗;在术后3 w末,超声检查发现PVT患者15例(25.0%),其中A组11例(36.7%),显著高于B组的4例【(13.3%),P<0.05】;血栓形成组门静脉直径为(1.5±0.3)cm,与无血栓形成组比,无显著性差异【(1.4±0.2)cm,P>0.05】,门静脉血流流速为(12.3±1.4)cm/s,显著低于无血栓形成组【(14.5±1.7)cm/s,P＜0.05】;血栓形成组血清D-二聚体水平显著高于无血栓形成组(P＜0.05);血栓形成组外周血血小板计数为(142.6±58.9)×10⁹/L,显著高于无血栓形成组【(91.4±52.4)×10⁹/L,P＜0.05】。结论在采取脾切除联合贲门周围血管离断术治疗肝硬化并发门脉高压症患者时,需警惕术后PVT的形成。对术后血小板计数急剧升高、血清D-二聚体显著升高和门脉血流减慢的患者应该及时给予抗凝治疗。

关键词: 肝硬化, 门脉高压症, 脾切除联合贲门周围血管离断术, 门静脉血栓, D-二聚体, 低分子肝素 , ,

Abstract: Objective The aim of this study was to investigate the prevention of portal vein thrombosis (PVT) in patients with cirrhotic portal hypertension after spleen resection and devascularization. Methods 60 patients with cirrhotic portal hypertension were recruited in our hospital between January 2017 and March 2019, and all underwent splenectomy and periorbital devascularization. After operation, the patients were randomly divided into group A (n=30) and group B (n=30), and the patients in group B were given very short-term anti-coagulant therapy when any parameters suggesting necessary. Results 20 patients (66.7%) out of 30 in group B received anti-coagulant therapy after operation, and at the end of three weeks, the sonography demonstrated PVT in 15 patient (25.0%), 11(36.7%) in group A and 4【(13.3%),P<0.05】 in group B; the portal diameter in patients with PVT was (1.5±0.3)cm, not significantly different compared to 【(1.4±0.2)cm, P>0.05】 in those without PVT, while the blood velocity in patients with PVT was (12.3±1.4)cm/s, much slower than 【(14.5±1.7)cm/s, P＜0.05】 in patients without; serum D-dimer level in patients with PVT was much higher than that in patients without PVT (P<0.05); the platelet count in patients with PVT was (142.6±58.9)×10⁹/L, significantly higher than thatin those without . Conclusion The application of splenectomy and devascularization in the treatment of patients with cirrhotic portal hypertension might lead to the PVT under some circumstances, and anti-coagulant therapy should be given in time to prevent it happening.

Key words: Cirrhosis, Portal hypertension, Splenectomy and devascularization, Portal vein thrombosis, D-dimer, Anti-coagulants

韩东,彭经纬,谢辉晋. 脾切除联合贲门周围血管离断术治疗肝硬化门脉高压症患者预防门静脉血栓形成研究[J]. 实用肝脏病杂志, 2020, 23(3): 409-412.

Han Dong, Peng Jingwei, Xie Huijin.. Prevention of portal vein thrombosis in patients with cirrhotic portal hypertension aftersplenectomy and devascularization[J]. Journal of Practical Hepatology, 2020, 23(3): 409-412.

参考文献

[1] Perera MT, Chen F. Portal vein thrombosis in cirrhosis: controversies and latest developments. World J Gastroenterol, 2015, 21(22): 6769-6784.
[2] 李晓东, 郑本波, 刘山. 脾切除联合贲门周围血管离断术治疗肝硬化并发门静脉高压症患者血细胞和肝功能的变化. 实用肝脏病杂志, 2018, 21(2): 289-290.
[3] Haris M, Thachil J. Portal vein thrombosis-a primer for the general physician. Clin Med (Lond), 2017,17(3): 212-219.
[4] Thornburg B, Desai K, Hickey R,et al. Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations. Tech Vasc Interv Radiol, 2016, 19(1): 52-60.
[5] Danila M, Sporea I, Popescu A, et al. Portal vein thrombosis in liver cirrhosis-the added value of contrast enhanced ultrasonography. Med Ultrason, 2016, 18(2): 218-233.
[6] Intagliata NM, Caldwell SH, Tripodi A, et al. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology, 2019,156(6): 1582-1599.
[7] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案. 中华传染病杂志, 2001, 19(1): 56-62.
[8] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪肝专家委员会.酒精性肝病防治指南(2018年更新版).实用肝脏病杂志,2018,21(2): 170-176.
[9] 王帅, 祁小龙. 门静脉高压的分类及诊断思路. 实用肝脏病杂志, 2018, 21(1): 14-17.
[10] Colecchia A, Marasco G, Taddia M, et al. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. Eur J Gastroenterol Hepatol, 2015, 27(9): 992-1001.
[11] Chinchilla-López P, Hamdan-Pérez N, Guerrero-Ixtlahuac J, et al. The role of tips in patients with refractory ascites and portal vein thrombosis. Ann Hepatol, 2017, 16(4): 619-620.
[12] Zhang ZY, Dong KS, Zhang EL, et al. Acute portal vein thrombosis after hepatectomy in a patient with hepatolithiasis: a case report and review of the literature. Medicine (Baltimore), 2018, 97(25): 111-174.
[13] Tantemsapya N, Superina R, Wang D,et al. Hepatic histology and morphometric measurements in idiopathic extrahepatic portal veinthrombosis in children, correlated to clinical outcome of meso-rex bypass. Ann Surg, 2018, 267(6): 1179-1184.
[14] Reslan OM, Kirsch JM, Kaul H, et al. Endovascular stenting of portal vein for graft rescue after a pancreas transplant venous graft thrombosis: a case report. Ann Vasc Surg, 2017, 42(1): 301- 303.
[15] Wang X, Luo X, Yang L, et al. The use of transjugular intrahepatic portosystemic shunt should be cautious in patients without cirrhosis with obliterativeportal vein thrombosis. Hepatology, 2016, 64(4): 1374-1375.
[16] Yoon JK, Kim MD, Lee DY, et al. Mesocaval shunt creation for jejunal variceal bleeding with chronicportal vein thrombosis. Yonsei Med J, 2018, 59(1): 162-166.
[17] 李相文, 涂明利. 早期应用低分子肝素预防腹腔镜脾切除食管胃底静脉断流术后门静脉血栓形成临床研究. 实用肝脏病杂志, 2017, 20(2): 179-182.
[18] Gastaca M, Prieto M, Palomares I, et al. Significance of measured intraoperative portal vein flows after thrombendvenectomy in deceased donor liver transplantations with portal vein thrombosis. Liver Transpl, 2018, 24(4): 565-566.
[19] Ohe M, Mutsuki T, Goya T, et al. Portal vein thrombosis repeatedly observed in a cirrhotic patient with antiphospholipid antibody syndrome. Fukuoka Igaku Zasshi, 2016,107(10): 185-90.
[20] Wosiewicz P,orniak M, Hartleb M, et al. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clin Res Hepatol Gastroenterol, 2016, 40(6): 722-729.
[21] 举古木乃, 王荣东, 胡格, 等. 腹腔镜食管胃底曲张静脉断流术联合脾切除或脾保留对肝硬化性门静脉高压症患者近远期预后的影响. 实用肝脏病杂志, 2018, 21(4): 601-604.
[22] Stine JG, Intagliata N, Northup PG, et al. Nonalcoholic fatty liver disease, portal vein thrombosis and coagulation: more questions than answers. Transplantation, 2017, 101(8): 281-282.
[23] Guerrero-Hernandez M, Hinojosa CA, Anaya-Ayala JE, et al. Endovascular reconstruction of extrahepatic portal vein in noncirrhotic and nonmalignant chronic portal vein thrombosis secondary to an iatrogenic stenotic lesion. Vasc Endovascular Surg, 2016, 50(8): 559-562.
[24] Habib A, Desai K, Hickey R, et al. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol, 2015, 26(4): 499-506.
[25] Fei Y, Zong GQ, Chen J, et al. Evaluation of the value of D-dimer, p-selectin, and platelet count for prediction of portal vein thrombosis after devascularization. Clin Appl Thromb Hemost, 2016, 22(5): 471-475.
[26] Malaguarnera M, Latteri S, Bertino G, et al. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. Clin Exp Gastroenterol, 2018, 11(1): 373-380.